Performance Characteristics of an HIV-1 Rapid Recency Assay Among Treatment-Naïve Individuals
AIDS Research and Human Retroviruses · 2025
DOI: 10.1089/aid.2024.0102 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift AIDS Research and Human Retroviruses, 2025. Verfasst von Xiaojuan Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Global HIV and TB, Global Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, HIV Antibodies. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Global HIV and TB, Global Health Center, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Bharat S Parekh
Förderung
- Intramural CDC HHS
Zitieren
APA
Tan, X., Detorio, M., Shanmugam, V., Dobbs, T., Yufenyuy, E. L., & Parekh, B. S. (2025). Performance Characteristics of an HIV-1 Rapid Recency Assay Among Treatment-Naïve Individuals. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2024.0102
Vancouver
Tan X, Detorio M, Shanmugam V, Dobbs T, Yufenyuy EL, Parekh BS. Performance Characteristics of an HIV-1 Rapid Recency Assay Among Treatment-Naïve Individuals. AIDS Research and Human Retroviruses. 2025. doi:10.1089/aid.2024.0102
BibTeX
@article{Tan2025,
author = {Tan, Xiaojuan and Detorio, Mervi and Shanmugam, Vedapuri and Dobbs, Trudy and Yufenyuy, Ernest L and Parekh, Bharat S},
title = {Performance Characteristics of an HIV-1 Rapid Recency Assay Among Treatment-Naïve Individuals},
journal = {AIDS Research and Human Retroviruses},
year = {2025},
doi = {10.1089/aid.2024.0102}
}
EUVIMED